Red Light Holland Successfully Imports 200 Psilocybin iMicrodose Packs, Sold in The Netherlands, Into Canada
Supreme Court says MRU student’s magic mushroom assault defence was valid In some highly controversial
Optimi Health Completes Expansion of On-site Analytical Laboratory Lab’s completion brings Company closer to full
Protestors of psilocybin ban arrested at DEA headquarters At least 17 activists were arrested for
Leveraging over 20 years of psychedelic research, Beckley Foundation is launching a psilocybin-focused holistic wellbeing
ATMA Submits Phase II Clinical Trial Application, Assessing Psilocybin Efficacy in Healthcare Professionals Suffering From
Mycrodose Therapeutics Successfully Delivers Both Macro and Microdose Levels of Psilocin Using Core Drug Delivery
Creso Pharma’s wholly-owned psychedelics subsidiary, Halucenex LifeSciences Inc. secures import permit from Health Canada Highlights:
Wesana Health Outlines Accelerated Drug Development Pathway CHICAGO and TORONTO, May 10, 2022 (GLOBE NEWSWIRE)
Connecticut Governor Signs Bill Creating Psychedelic Treatment Program The governor of Connecticut signed off on
“Minor” Magic Mushroom Compound Crystal Structure Solved While psilocybin continues to receive attention as the active ingredient
Optimi Health Applauds Health Canada’s Position on Drug Quality and Goods and Manufacturing Practices (GMP)
COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults COMPASS Pathways (CMPS) is
PsyBio Therapeutics Initiates Blood-Brain Barrier Permeability Testing for Pipeline Compounds to Enhance Portfolio Development PsyBio
Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and
Cybin Announces CYB003 Poster to be Presented at the ‘From Research to Reality’ Global Summit
Psilo Psoirée is an online community that allows psychedelic explorers to connect before and after their
Large survey suggests psilocybin is a “relatively safe” drug, with serious reactions being rare and
Nova Mentis Psilocybin Manufacturer Receives Approved Health Canada Importation Permit Phase 2A Microdose Clinical Study
Optimi Health Granted Amendment to Controlled Substances Dealer’s Licence Request to modify quantities of psilocybin
Optimi Health Opens Canada’s Largest GMP-Grade Licensed Psilocybin Cultivation Facility Optimi Health (OPTI) opened the
Tryp Therapeutics Doses First Patient in Phase II Psilocybin-assisted Therapy Clinical Trial Phase II trial
This Ottawa store is selling magic mushrooms to protest ‘unjust’ laws The Golden Teacher is
Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the
